Blood Compatibility of Hydrophilic Polyphosphoesters

Area of Science:

• Polymer Science
• Biomaterials Science
• Hemocompatibility Studies

Background:

• Polyphosphoesters (PPEs) are versatile degradable polymers with significant biomedical potential.
• Limited data exists on the hemocompatibility of PPEs, hindering their clinical translation.
• Understanding blood interactions is crucial for developing safe and effective biomaterials.

Purpose of the Study:

• To evaluate the hemocompatibility of water-soluble polyphosphoesters (PPEs) with varying properties.
• To assess the blood compatibility of PPE-coated nanocarriers.
• To compare PPE hemocompatibility with poly(ethylene glycol) (PEG).

Main Methods:

• In vitro hemocompatibility assays were performed on water-soluble PPEs of different hydrophilicities and molar masses.
• Blood coagulation, platelet activation, red blood cell lysis, and aggregation were measured.
• Hemocompatibility of PPE-coated model nanocarriers was assessed.

Main Results:

• Hydrophilic PPEs exhibited high hemocompatibility, comparable to PEG.
• No significant changes in blood coagulation, platelet activation, or red blood cell integrity were observed with hydrophilic PPEs.
• A hydrophobic PPE copolymer showed minor effects on clot strength only at high concentrations, exceeding typical biomedical usage levels.
• PPE-coated nanocarriers demonstrated excellent hemocompatibility.

Conclusions:

• Hydrophilic polyphosphoesters (PPEs) are highly hemocompatible and suitable for biomedical applications.
• PPEs offer a promising alternative to PEG for developing degradable and biocompatible nanomedicine platforms.
• Further research can leverage PPEs for advanced, safe, and effective medical devices and drug delivery systems.